This guideline has been set out for author to assess minimum requirements for the review process, to meet the standards of paper, to accept best practice. It refers to the guidelines of Enfermeria Clinica Journal for the structure of the manuscripts.


Submission checklist

You can use this list to carry out a final check of your submission before you send it to the 2nd INSC committee for review process.

Ensure that the following items are present:

 One author has been designated as the corresponding author with contact details:

  • E-mail address
  • Full postaladdress

All necessary files have been uploaded:


  • Include key words
  • All figures (include relevant captions)
  • All tables (including titles, description, footnotes)
  • Ensure all figure and table citations in the text match the files provided
  • Indicate clearly if color should be used for any figures in print Graphical Abstracts / Highlights files (where applicable)
  • Supplemental files (where applicable)

Further considerations

  • Manuscript has been ‘spell checked’ and ‘grammar checked’
  • All references mentioned in the Reference List are cited in the text, and vice versa
  • Permission has been obtained for use of copyrighted material from other sources (including the Internet)
  • A competing interests statement is provided, even if the authors have no competing interests to declare



It must briefly and concisely indicate the contents of the manuscript and it has to provide the maximum information with the minimum number of words (it recommended not to exceed 15). It must not include acronyms. A short title should be included with a maximum of 80 characters with spaces.

Abstract and Keywords:

For Original and Short Original works, it has to be structured into the following sections: Objective, Method, Results (most important 3-4) and Conclusion (1-2, arising from the results). It should contain sufficient information for the reader to have a clear idea of the contents of the manuscript. It should not contain information that cannot be found later in the manuscript. On the same page it will give between 3 and 6 keywords, directly related to the topic presented in the manuscript. MeSH terms (Medical Subject Headings) should be used or the Health Sciences Descriptors (Decs) so that they can be classified in the international databases.

Text or body of the manuscript:

It is advisable to divide the work clearly into sections, depending on the section to which it may be submitted: Originals and Short Originals: Introduction, Method, Results, and Discussion.


The introduction should include the definition of the basic concepts, contextualize the topic of study, justify its relevance and expose the current state of the topic. In the last part the objectives of the study will be defined. It will be as brief as possible, and its basic rule is to provide the basic information necessary for the reader to be able to understand the text that follows later. All of this supported with the most current and important literatur rereferences.


An exhaustive description must be provided on how the study has been performed, with sufficient information so that other researchers can replicate it; that is, that they can perform it without consulting the authors.

Its content will be determined by the objectives of the study. It will contain several sub-sections that do not need to be specified in the text.


The type of study performed must be mentioned, justifying, if necessary, the reasons for its choice.

Population and Study Setting:

Indicate the place and the date of performing the study. Specify the characteristics of the studied population and the inclusion and exclusion criteria. If all the population has not been studied, it must indicate how the sample size was calculated and the value of the parameters used, as well as the sampling technique.


Define all the variables that have been collected, determined by the objectives established, particularly the variables of the most important results. If it is an experimental study, it must mention the intervention made (also of the control group, if relevant and the follow-up time. Data collection: Explain how the data have been collected and who did it, as well as the tools used for this purpose, indicating if they are validated and the corresponding literature reference.

Data Analysis:

Mention the statistics program used for the analysis and the analysis performed. Indicate the strategy used for the literature review, that is, data bases reviewed, the descriptors or keywords employed in the search and the years reviewed.

Ethical Aspects:

It must be specified, in the case of research studies, whether it has been approved by the corresponding Ethics Committee, and whether it complies with the requirement established in national and international guidelines for clinical trials and similar studies as applicable.


It must only include the most important results, according to the objectives and the statistical analysis mentioned in the Method section. The results must respond exactly to the objectives that have been established and must make clear whether or not they certify the working hypothesis. There should not be any objective in the introduction that is not given a response in the results and any objective not mentioned in the introduction should not have a response in the results. Assessments or comments on the results obtained should also not be included in this section.

In general, it should start with a description of the study subjects, to specifically know the number studied and their characteristics. If, subjects have been lost during the study, or it has not been able to contact, with the total of the sample selected, it must also indicate both the number and the reason. After the description of the subjects, a descriptive analysis of the most important variables will be presented, according to the measurement scale, and the most suitable manner to describe them will be chosen, attempting to provide the best information about each one (thus, frequencies and percentages will be used for the nominal qualitative variables, and for the quantitative ones, mean and standard deviation when they follow a normal distribution, etc.). The corresponding confidence intervals will also be indicated.

If there is more than one study group, each one must be characterised, and later indicate the comparisons between these groups in terms of statistical significance a magnitude of the difference and, above all, in terms of clinical relevance. Statistical tests that have not been described in the Method section must not be employed, and their results must be accompanied by a statistical value, degrees of freedom and statistical significance (P value), and the confidence interval (where appropriate). To indicate the P value, it is advisable not to use more than 3 decimals (P=.002); thus, a value of P=.000001 may be expressed as P Tables and/or Figures can be used to complement the information, not to duplicate it. The Tables and Figures must be sufficiently clear to be able to interpret them with the need to refer to the text. If abbreviations or initials are used, they must be explained in the Table or Figure footnotes.

If there is more than one study group, each one should be characterized, and then indicate the comparisons between these groups in terms of statistical significance and magnitude of the difference and, above all, in terms of clinical relevance.

After describing the subjects, the descriptive analysis of the most important variables will be presented, according to the measurement scale, and the most appropriate way to describe them will be chosen, trying to provide the best information about each one (thus, for the qualitative variables nominal frequencies and percentages will be used, for the quantitative, mean and standard deviation when following a normal distribution, etc.). The corresponding confidence intervals will also be indicated.


In this section, the authors must express their opinions on study topic and the results obtained, avoiding repetition of the information that has been given in the Results or in the Introduction. Comparison should be made with the results obtained in other studies, with the corresponding literature references. Mention should be made of the possible limitations of the study that could determine the interpretation of the results. The conclusions and the appropriate recommendations will be reflected, as well as suggestions for future studies on the topic and the implications that it has for the practice. The Discussion, as in the Conclusions, must arise directly from the results, and comments or statements that are not associated with the results obtained in the study must be avoided. It should also take into account, that although statistically significant differences are found in the hypothesis contrasts, these differences may not be relevant in clinical practice and, therefore, there should be caution when interpreting them. In the discussion should include the limitations of the study and finalize the conclusions within this same section, without indicating a specific heading for it.


The adapting of the literature references to the Vancouver Style and their accuracy are the responsibility of the authors, therefore it is advised to make an exhaustive review of these and check them with the original documents, so that they do not contain errors that could hinder locating them by interested readers. The literature reference must be consecutively numbered using Arabic numbers in superscript according to their appearance in the text for the first time. When they coincide with a punctuation sign, the citation will always precede that sign. Examples on how to write literature reference can be consulted on the page: The bibliographical references should be numbered correlatively according to their appearance in the text for the first time, with Arabic numerals flown. When they match a punctuation mark, the quote will always precede that sign.

It is recommended that the bibliographic references included should not be more than 10 years old, and that at least half of them be less than 5 years old, including references from prestigious journals.

 Tables and Figures:

The Tables will be presented at the end of the manuscript, one on each page, with the title in their upper part and numbered with Arabic numerals, in the order that they appear in the text. The Figures must be submitted in a separate file, also with a title and numbered in order of appearance. The Figures and Tables must not repeat the results that have been mentioned in the text and must be clear; they should not have to refer to the text to be able to understand their content, thus, the title must be explanatory and must be accompanied by the necessary clarification footnotes.

Reference style

Text: Indicate references by superscript numbers in the text. The actual authors can be referred to, but the reference number(s) must always be given.

List: Number the references in the list in the order in which they appear in the text.


Reference to a journal publication:

  1. Vander Geer J, Hanraads JAJ, LuptonRA. The art of writing a scientific article. JSci Commun

2010; 163: 51–9.

Reference to a journal publication with an article number:

  1. Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. Heliyon. 2018;19: e00205. doi:10.1016/j.heliyon.2018.e00205.

Reference to a book:

  1. Strunk Jr W, White EB. The elements of style. 4th ed. New York: Longman; 2000.

Reference to a chapter in an edited book:

  1. Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith RZ, editors. Introduction to the electronic age, New York: E-Publishing Inc; 2009, p. 281–304.

Reference to a website:

  1. Cancer Research UK. Cancer statistics reports for the UK,; 2003 [accessed 13 March2003].



  1. The poster must correspond to the title and content of the submitted abstract
  2. The poster must be in portrait orientation, be designed to fit within the confines of an A1 Paper (594 mm x 841 mm) and be made of material that can be mounted easily with push pins/ double tape
  3. The poster must be arranged in logical sequence, i.e Introduction, Methods, Results, Discussion, Conclusion.
  4. Poster should be visible from a distance of beyond 1 meter, use large font size or letters, and avoid excessive text.
  5. Design the poster creatively (with appropriate combined colors or images and simple background) to visually enhance it but not too distracting, aim it for simplicity and clarity.
  6. The printed poster must be submitted at 13 November 2018 during the first day registration. Committee will not receive any posters that has not yet been printed out.


Oral Presentation Terms & Conditions

  1. These terms and conditions apply to oral presentation.
  2. Manuscript of oral presentation should pass the selection processes conducted by the reviewer.
  3. Oral presentation may be in the form of a power point presentation, or any other presentation format.
  4. During the conference, the presentation time given will be 12 minutes at best. Presenters are urged to keep strictly to the time limit. The moderator representative may cut the presentation if it has exceeded the allocated time. Oral presenters are responsible for providing all printed copies of any document required for the presentation; Committee will not provide any printout of any submitted documents or manuscripts.
  5. Presentation delivered by other authors listed in the manuscripts is allowed
  6. If the presenter does not have any accounts in INSC’s website, He/She should sumbit the statement letter to the committee, no longer than November 13th 2018
  7. The name that will be written within the certificate as an oral presenter is the person’s name who give the whole presentation.
  8. The PPT must be submitted before November 12, 2018 so we can upload your material to the computer in the presentation room. To those who already submitted, please make sure to check your material with us at the Faculty of Nursing, Universitas Indonesia on November 13, 2018 at 10 AM.

All presenters must register and pay the appropriate registration fees. Pre-registration is available until November 2, 2018.